Methyl(3s,4s)-4-methylpiperidine-3-carboxylate;hydrochloride, 98%, 500mg

2-Iodo-4-nitroanisole, 98.0%, 25g

(R)-2-Aminohex-5-enoic acid, 95.0%, 1g

3-(Aminomethyl)-4,6-dimethylpyridin-2(1H)-one hydrochloride, 95.0%, 5g

Morpholin-4-ylacetic acid hydrochloride, 97.0%, 1g

D 358>95.0%(HPLC)50mg

3-Chloro-2-fluoro-5-(trifluoromethyl)benzylbromide, 5g

Hydrogen peroxide, 30%, for synthesis, stabilized, 2.5L, plastic packaging.

4,7-DIAZASPIRO[2.5]OCTANE-5,8-DIONE, 95.0%, 10g

3-(4-ethylphenyl)-1-methyl-1{H}-pyrazole-5-carboxylic acid, 95.0%, 500mg

4-Hydroxybenzoic acid, 99.0%, 1g

6-hydroxy-2-(thiophen-3-yl)-1,4-dihydropyrimidin-4-one, 10g

ROTI®Cell Leibovitzs L15